Ayan Abdrakhmanov

Ayan Abdrakhmanov


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Heart Rhythm
Verified
Journal Article
Closed access
ELEvgeny Lian
Evgeny Lian
MTMauro Toniolo
Mauro Toniolo
ATAlexey Tsyganov
Alexey Tsyganov
LRLuca Rebellato
Luca Rebellato
APAlessandro Proclemer
Alessandro Proclemer
MYMarina Yakovleva
Marina Yakovleva

1 January 2024 in Therapeutic Advances in Cardiovascular Disease
Verified
Journal Article
Open access
AAAyan Abdrakhmanov
Ayan Abdrakhmanov
ASAizhana Shaimerdinova
Aizhana Shaimerdinova
ZSZhanasyl Suleimen
Zhanasyl Suleimen
SASvetlana Abildinova
Svetlana Abildinova
RARustam Albayev
Rustam Albayev
MBMakhabbat Bekbossynova
Makhabbat Bekbossynova
Atrial fibrillation (AF) accounts for 40% of all cardiac arrhythmias and is associated with a high risk of stroke and systemic thromboembolic complications. Dabigatran, rivaroxaban, apixaban, and edoxaban are direct oral anticoagulants (DOACs) that have been proven to prevent stroke in patients with non-valvular AF. This review summarizes the pharmacokinetics, pharmacodynamics, and drug interactions of DOACs, as well as new data from pharmacogenetic studies of these drugs. This review is aimed at analyzing the scientific literature on the gene polymorphisms involved in the metabolism of DOACs. We searched PubMed, Cochrane, Google Scholar, and CyberLeninka (Russian version) databases with keywords: ‘dabigatran’, ‘apixaban’, ‘rivaroxaban’, ‘edoxaban’, ‘gene polymorphism’, ‘pharmacogenetics’, ‘ ABCB1’, ‘ CES1’, ‘ SULT1A’, ‘ ABCG2’, and ‘ CYP3A4’. The articles referred for this review include (1) full-text articles; (2) study design with meta-analysis, an observational study in patients taking DOAC; and (3) data on the single-nucleotide polymorphisms and kinetic parameters of DOACs (plasma concentration), or a particular clinical outcome, published in English and Russian languages during the last 10 years. The ages of the patients ranged from 18 to 75 years. Out of 114 reviewed works, 24 were found eligible. As per the available pharmacogenomic data, polymorphisms affecting DOACs are different. This may aid in developing individual approaches to optimize DOAC pharmacotherapy to reduce the risk of hemorrhagic complications. However, large-scale population studies are required to determine the dosage of the new oral anticoagulants based on genotyping. Information on the genetic effects is limited owing to the lack of large-scale studies. Uncovering the mechanisms of the genetic basis of sensitivity to DOACs helps in developing personalized therapy based on patient-specific genetic variants and improves the efficacy and safety of DOACs in the general population.

1 July 2022 in Current Cardiology Reviews
Verified
Journal Article
Open access
PDF file
IRIdaliya Rakhimova
Idaliya Rakhimova
YSYuliya Semenova
Yuliya Semenova
TKTalgat Khaibullin
Talgat Khaibullin
AKAnargul Kuanysheva
Anargul Kuanysheva
VKVitalii Kovalchuk
Vitalii Kovalchuk
AAAyan Abdrakhmanov
Ayan Abdrakhmanov
Background: Stroke is a problem worldwide because of its high mortality and disability rates. Almost 90% of strokes are ischemic, and more than half of the deaths are caused by an ischemic stroke. Most risk factors for stroke are manageable so that it can be avoided with proper prevention. Despite the success in determining the causes of stroke in recent years, selectively, the “culprit” causing stroke remains unsolved. In such cases, a diagnosis of undetermined etiology (cryptogenic stroke) or embolic stroke of undetermined source (ESUS) is generated, resulting the prevention of a recurrent cerebrovascular occurrence impossible. Atrial fibrillation (AF) can be a cause of stroke by causing blood clots in the chambers of the heart. Purpose: The aim was to determine the optimal method of heart rate monitoring in patients with ischemic stroke, as methods and approaches for detecting AF are very diverse, but there is still no single opinion, which would be universal. Procedures: In our review, we consider epidemiology, risk factors for the stroke of undetermined etiology, as well as analytical methods for detecting heart rhythm disturbances in this category of patients. Findings: Atrial fibrillation (AF) is detected by thorough monitoring of heart rate of patients with cryptogenic stroke and ESUS can be diagnosed in up to 46% of patients. Conclusion: After AF detection, consideration should be given to prescribing anticoagulants, instead of antiplatelet agents, for the secondary prevention of stroke.

1 June 2024
Verified
Journal Article
Open access
AAAyan Abdrakhmanov
Ayan Abdrakhmanov
EZElena Zholdybayeva
Elena Zholdybayeva
ASAizhana Shaimerdinova
Aizhana Shaimerdinova
GKGulmira Kulmambetova
Gulmira Kulmambetova
SASvetlana Abildinova
Svetlana Abildinova
MBMakhabbat Bekbossynova
Makhabbat Bekbossynova
Background : Allelic variants of genes encoding enzymes of the esterase system ( CES1 ) and P-glycoprotein ( ABCB1 ) can change the metabolism and pharmacokinetics of dabigatran. Therefore, they act as determining factors in the development of side effects, especially bleeding. We analyzed the genotype-phenotype relationship of ABCB1 (rs1045642, rs4148738, rs2032582, and rs1128503) and CES1 (rs8192935, rs71647871, and rs2244613) polymorphisms in patients with atrial fibrillation who had been treated with dabigatran. Methods: A total of 150 patients were recruited for this study. TaqMan technology was used for SNP genotyping. Results: Patients with the rs2244613 GG genotype had a lower concentration (55.27 +/- 34.22 ng/ml) compared to those with the TT genotype (63.33 +/- 52.25 ng/ml) (additive model, P = 0.000). Individuals with the rs8192935 AA genotype had a lower concentration (52.72 +/- 30.45 ng/ml) compared to those with the GG genotype (79.78 +/- 57 ng/ml) (additive model, P = 0.001). The APTT values among the different genotypes of the ABCB1 SNPs, rs4148738 and rs1045642, were significantly different (P = 0.035 and P = 0.024, respectively). Conclusion : Our research demonstrates that the CES1 polymorphisms, rs8192935 and rs2244613, are associated with the pharmacodynamics and pharmacokinetics of dabigatran in the Kazakh subpopulation.

16 May 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
NGNigar Z. Gasimova
Nigar Z. Gasimova
ANAnatoly A. Nechepurenko
Anatoly A. Nechepurenko
EKEvgeny B. Kropotkin
Evgeny B. Kropotkin
EIEduard A. Ivanitsky
Eduard A. Ivanitsky
GKGrigorii V. Kolunin
Grigorii V. Kolunin
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov

31 January 2022 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
IRI. R. Rakhimova
I. R. Rakhimova
TKT. N. Khaibullin
T. N. Khaibullin
VKV. V. Kovalchuk
V. V. Kovalchuk
YSYu. M. Semenova
Yu. M. Semenova
AAAyan Abdrakhmanov
Ayan Abdrakhmanov
Aim To identify a complex of predictors and to create a mathematical model for prognosis of atrial fibrillation (AF) in patients with ischemic stroke of undetermined etiology. Material and methods   The study included 981 patients with ischemic stroke. Effects of the following factors were evaluated: gender, a history of stroke, a history of thromboembolism, presence of diabetes mellitus, grade of arterial hypertension, functional class (FC) of chronic heart failure (CHF), age, data of blood biochemistry, and data of coagulogram. The prognostic model was constructed using the binary logistic regression. The value of area under the ROC curve for the proposed prognostic model was calculated. Results The main predictors of AF in patients with ischemic stroke of undetermined etiology were CHF FC, a history of stroke, age, gender, values of cholesterol and prothrombin index, which were included into the final prognostic model. The sensitivity of the developed model was 83.5 % and the specificity was 85.5 %. The area under the ROC curve corresponding to the interrelation between the prognosis of AF and the regression function value was 0.921±0.012 with 95 % confidence interval: 0.898–0.944. Conclusion According to the results of the study, the probability of AF in patients with ischemic stroke increased with CHF progression, recurrent stroke, older age, female gender, and reduced prothrombin index and cholesterol level.